June 27, 2019
Regeneron, Sanofi’s Dupixent OK’d by FDA for combos to treat certain nasal diseases
Regeneron Pharmaceuticals and Sanofi got the approval from the FDA for Dupixent for certain combinations to treat chronic rhinosinusitis with nasal polyposis (CRSwNP) in adults whose disease is not controlled.